Deutsch (DE-CH-AT)English (United Kingdom)Russian (CIS)
  • Increase font size
  • Default font size
  • Decrease font size
Please wait while JT SlideShow is loading images...
Nanostart AGNanostart AG


Transparency disclosures

Nanostart AG publishes 2011 half-year figures

Transparency declaration pursuant to Section 17 (2) of the General Terms and Conditions for the over-the-counter market

  • The company’s best-ever half-year result
  • Delays at Nanostart subsidiary MagForce
  • New cleantech investment in Singapore

Frankfurt – August 5, 2011 – Frankfurt-based nanotechnology investment company Nanostart AG today announced a half-year profit under German GAAP of T€ 1,537 for the first half of 2011 (previous year: T€ 923). This is a 66% increase on the half-year result of the previous year, making it the company's best-ever. In the first half of 2011, key areas of operating activities were expanding the portfolio and preparing for further international expansion.

Read more...

Nanostart AG Publishes Figures for 2010 Fiscal Year

 Transparency report in accordance with §17 Section 2 of the general terms and conditions for open markets

Frankfurt am Main – May 31, 2011 – For the 2010 fiscal year, Frankfurt-based nanotechnology investment company Nanostart AG reports the biggest profit in its company history. Net income under German GAAP totaled €2.48 million, up 106 percent on the previous year (2009: €1.2 million). This means another successful year for Nanostart, which has been profitable from the beginning of operations.

Read more...

Nanostart AG announces record numbers for the first half of 2010

Transparency report in accordance with §17 Section 2 of the general terms and conditions for open markets

  • Best first half of year in company history
  • Net asset value increases to nearly EUR 144 million
  • Cash influx from BioMicro transaction not yet included

Frankfurt am Main – September 21, 2010 – Frankfurt-based nanotechnology company Nanostart AG is reporting the best first-half results since the company was founded for the first six months of 2010. In accordance with commercial code, semi-annual net profit totaled EUR 923,000 (previous year EUR -1.4 million). Earlier in the year, Swiss company and global market leader Roche Diagnostics purchased the main product line of American Nanostart holding BioMicro Systems, Inc. Revenues from this transaction are however not included in semi-annual numbers, as the cash transfer took place after the June 30, 2010 reporting date.

Read more...

Nanostart successfully completes capital increase

Frankfurt – March 30, 2010 - Nanostart AG has issued 330,000 new shares in conjunction with an increase in its approved capital under the procedure to exclude subscription rights for existing investors.

Read more...

Nanostart AG successfully completes capital increase

Frankfurt - December 5, 2008 - Nanostart AG has issued 360,000 new shares in conjunction with an increase in its approved capital. In doing so, the company has availed itself of the simplified procedure to exclude subscription rights in accordance with Sec. 186 Par. 3 setence 4 of the German Stock Corporation Act (Aktiengesetz).

Read more...

Page 1 of 2

  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
You are here: Investor relations >> Transparency disclosures